Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEXHONG KONG, Dec 13, 2022 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"). The Group intends to offer an aggregate of 54,633,000 shares, of which 49,169,000 shares will be for the International Offering (subject to reallocation) and 5,464,000 shares will be for the Hong Kong Public Offering (subject to reallocation). The offer price is HK$8.80 per Offer Share. The estimated net proceeds from the Global Offering will amount to approximately HK$366.8 million, after deducting underwriting commissions and other estimated expenses paid and payable by the Group in connection with the Global Offering.
